Literature DB >> 9820943

A surgical technique for posterior lamellar keratoplasty.

G R Melles1, F A Eggink, F Lander, E Pels, F J Rietveld, W H Beekhuis, P S Binder.   

Abstract

PURPOSE: To design a surgical technique for transplantation of posterior corneal tissue, while leaving the recipient anterior cornea intact.
METHODS: In human cadaver eyes, and in a cat and monkey model, recipient eyes had an 8.0-mm limbal incision made with a diamond blade set to 50% of central pachymetry. A stromal pocket was created across the cornea, and a 6.0-mm diameter posterior lamellar disc was excised. A donor posterior disc was implanted into the recipient opening, and the limbal incision was sutured. The procedure was evaluated with keratometry, biomicroscopy, endothelial (supra)vital staining, and light microscopy.
RESULTS: In human cadaver eyes, post-operative astigmatism averaged 1.2 D (SD, +/- 0.6 D). Posterior transplants showed an intact endothelial cell layer with 1.0% (SD, +/- 1.2%) of cell death. In the animals, six (75%) eyes had clear transplants 2 weeks after surgery; one of these eyes later developed an allograft rejection. Two (25%) eyes showed corneal decompensation, because of inverted implantation of the donor disc. Microscopy showed minimal scarring at the donor-to-host interface and a normal wound-healing response at the posterior stromal wound edges.
CONCLUSION: In experimental models, posterior lamellar keratoplasty can be performed through a limbal incision and a mid-stromal pocket. The procedure may be a potential alternative in the surgical management of corneal endothelial disorders.

Entities:  

Mesh:

Year:  1998        PMID: 9820943     DOI: 10.1097/00003226-199811000-00010

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  119 in total

1.  [Corneal wound healing. II. Treatment of disorders of wound healing].

Authors:  P W Rieck; U Pleyer
Journal:  Ophthalmologe       Date:  2003-12       Impact factor: 1.059

2.  [Influence of corneal thickness on intraocular pressure measurements following Descemet's stripping automated endothelial keratoplasty (DSAEK)].

Authors:  M K J Klamann; A-K B Maier; J Gonnermann; N Torun; P C Ruokonen
Journal:  Ophthalmologe       Date:  2012-11       Impact factor: 1.059

Review 3.  [DMEK: Descemet membrane endothelial keratoplasty].

Authors:  C Cursiefen; F E Kruse
Journal:  Ophthalmologe       Date:  2010-04       Impact factor: 1.059

4.  A new donor cornea harvesting technique for posterior lamellar keratoplasty.

Authors:  O Suwan-apichon; M Rizen; J M G Reyes; S Herretes; A Behrens; W J Stark; R S Chuck
Journal:  Br J Ophthalmol       Date:  2005-09       Impact factor: 4.638

Review 5.  [Lamellar keratoplasty. Back to the future?!].

Authors:  G Geerling; G I W Duncker; J Krumeich; G R J Melles
Journal:  Ophthalmologe       Date:  2005-12       Impact factor: 1.059

6.  Overcoming the technical challenges of deep lamellar keratoplasty.

Authors:  M Yamada
Journal:  Br J Ophthalmol       Date:  2005-12       Impact factor: 4.638

7.  Properties of corneas reconstructed with cultured human corneal endothelial cells and human corneal stroma.

Authors:  Shiro Amano; Tatsuya Mimura; Satoru Yamagami; Yasuhiro Osakabe; Kazunori Miyata
Journal:  Jpn J Ophthalmol       Date:  2005 Nov-Dec       Impact factor: 2.447

Review 8.  Surgical alternatives to penetrating keratoplasty II: endothelial keratoplasty.

Authors:  Kenneth M Goins
Journal:  Int Ophthalmol       Date:  2008-06       Impact factor: 2.031

9.  Cost-Effectiveness Analysis of Descemet's Membrane Endothelial Keratoplasty Versus Descemet's Stripping Endothelial Keratoplasty in the United States.

Authors:  Allister Gibbons; Ella H Leung; Sonia H Yoo
Journal:  Ophthalmology       Date:  2018-09-28       Impact factor: 12.079

10.  Differences in the TGF-{beta}1-induced profibrotic response of anterior and posterior corneal keratocytes in vitro.

Authors:  Holly B Hindman; Jennifer N Swanton; Richard P Phipps; Patricia J Sime; Krystel R Huxlin
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-11-11       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.